Tuberculosis

Arcady Group Awarded Grant to Continue TB Medication Adherence Initiatives
Arcady Group Awarded Grant to Continue TB Medication Adherence Initiatives 2560 1707 The Arcady Group

Factors Associated With Non-Adherence to Tuberculosis Treatment in Kenya
Factors Associated With Non-Adherence to Tuberculosis Treatment in Kenya 2000 1333 The Arcady Group

Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis
Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis 1000 899 The Arcady Group

Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care
Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care 2560 1707 The Arcady Group

WHO Consultation On Digital Health for the End TB Strategy
WHO Consultation On Digital Health for the End TB Strategy 900 900 The Arcady Group

47th Union World Conference on Lung Health
47th Union World Conference on Lung Health 2000 1333 The Arcady Group
  • 1
  • 2
Accelerating the availability and uptake
of life-saving technologies and medications for patients who need them most.
Meet our leadership.

Navigation

Home
Who We Are
Our Work
New & Resources
Contact Us

Latest Resources

Tuberculosis
Toolkits
Adherence
Innovative Technologies
Special Reports

Stay Connected

©2022 The Arcady Group. All Rights Reserved.

Start Typing
Back to top